Related Experiment Videos
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells
D Bandyopadhyay1, M Mandal, L Adam
1Department of Clinical Investigation, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Binding of extracellular ligands to epidermal growth factor receptors (EGFR) activate signal transduction pathways associated with cell proliferation, and these events are inhibited by monoclonal antibodies against EGFR. Since efficient DNA repair in actively growing cells may require growth factor signaling, it was of interest to explore any linkage between EGFR-mediated signaling and DNA-dependent protein kinase (DNA-PK), an enzyme believed to be involved in repairing double strand breaks and V(D)J recombination. We report that anti-EGFR monoclonal antibodies (mAbs), and not EGFR ligands, trigger a specific early physical interaction between EGFR and a 350-kDa catalytic subunit of DNA or its regulatory heterodimeric complex Ku70/80, in a variety of cell types, both in vivo and in vitro. Inhibition of EGFR signaling by anti-EGFR mAb was accompanied by a reduction in the levels of the DNA-PK and its activity in the nuclear fraction. Confocal imaging revealed that a substantial amount of DNA-PK was co-localized with EGFR in anti-EGFR mAb-treated cells. Anti-EGFR mAb-induced physical interaction between EGFR and DNA-PK or Ku70/80 was dependent on the presence of EGFR, but not on the levels of EGFR. The EGFR associated with DNA-PK or Ku70/80 retains its intrinsic kinase activity. Our findings demonstrate the existence of a novel cellular pathway in mammalian cells that involves physical interactions between EGFR and DNA-PK or Ku70/80 in response to inhibition of EGFR signaling. Our present observations suggest a possible role of EGFR signaling in maintenance of the nuclear levels of DNA-PK, and interference in EGFR signaling may possibly result in the impairment of DNA repair activity in the nuclei in anti-EGFR mAb-treated cells.
Insights
Monoclonal antibodies targeting epidermal growth factor receptors (EGFR) induce a novel interaction between EGFR and DNA-dependent protein kinase (DNA-PK), potentially impacting DNA repair in treated cells.
Area of Science:
- Cellular biology
- Molecular oncology
- DNA repair mechanisms
Background:
- Epidermal growth factor receptors (EGFR) regulate cell proliferation via signaling pathways.
- Monoclonal antibodies (mAbs) against EGFR inhibit these proliferative signals.
- DNA-dependent protein kinase (DNA-PK) is crucial for DNA double-strand break repair and V(D)J recombination.
Purpose of the Study:
- To investigate the potential link between EGFR signaling and DNA-PK activity.
- To explore the effect of anti-EGFR mAbs on the interaction between EGFR and DNA-PK components.
- To elucidate a novel cellular pathway involving EGFR and DNA repair machinery.
Main Methods:
- Utilized various cell types in vitro and in vivo.
- Employed anti-EGFR monoclonal antibodies (mAbs) and EGFR ligands.
- Performed confocal imaging to assess co-localization of EGFR and DNA-PK/Ku70/80.
- Measured DNA-PK levels and activity in nuclear fractions.
Main Results:
- Anti-EGFR mAbs, but not ligands, induced physical interaction between EGFR and DNA-PK or Ku70/80.
- EGFR signaling inhibition by anti-EGFR mAb reduced nuclear DNA-PK levels and activity.
- Confocal imaging showed EGFR co-localization with DNA-PK in treated cells.
- The interaction was EGFR-dependent but independent of EGFR levels, with EGFR retaining kinase activity.
Conclusions:
- A novel cellular pathway exists where EGFR interacts with DNA-PK or Ku70/80 upon EGFR signaling inhibition.
- EGFR signaling may maintain nuclear DNA-PK levels.
- Interference with EGFR signaling by anti-EGFR mAbs could impair nuclear DNA repair activity.